Results 131 to 140 of about 15,566 (231)

CYP3A5*8 Allele [PDF]

, 2020
openaire   +1 more source

Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes

Pharmacogenomics and Personalized Medicine
Thi Van Anh Nguyen,1,* Ba Hai Le,2,* Minh Thanh Nguyen,2,* Viet Thang Le,3,* Viet Tien Tran,4,* Dinh Tuan Le,5,* Duong Anh Minh Vu,2,* Quy Kien Truong,3,* Trong Hieu Le,2,* Huong Thi Lien Nguyen2,* 1Department of ...
Nguyen TVA, Le BH, Nguyen MT, Le VT, Tran VT, Le DT, Vu DAM, Truong QK, Le TH, Nguyen HTL   +9 more
doaj  

CYP3A5*10 Allele [PDF]

, 2020
openaire   +1 more source

Relationship of CYP3A5 genetic polymorphism and efficacy of calcium channel blockers in the treatment of Chinese end-stage renal disease patients

Linchuang shenzangbing zazhi, 2016
Objective To analyze the relationship between CYP3A5 genotype and antihypertensive effect of the calcium channel blockers(CCB).Methods We studied 215 maintenance hemodialysis or peritoneal hemodialysis patients from the Haikou Xiangya Hospital of Central
ZHOU Jun, CHEN Ju
doaj  

CYP3A5*3 Allele [PDF]

, 2020
openaire   +1 more source

Cohort Study to Determine the Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Heart Transplant Recipients. [PDF]

Pharmacotherapy
Wu Y, Eadon MT, Schenkelberg L, Rao RA, Skaar TC, Tillman EM, Shugg T.   +6 more
europepmc   +1 more source

Pharmacogenetics of CYP3A5 in Pediatric Patients With Eosinophilic Esophagitis. [PDF]

Clin Transl Sci
Noel-MacDonnell J, Almahbub N, Boone E, Wang W, Cheranova D, Harvey L, Shakhnovich V, Chevalier R.   +7 more
europepmc   +1 more source

CYP3A5 wt Allele [PDF]

, 2020
openaire   +1 more source

Donor and recipient genetic polymorphisms modulate tacrolimus pharmacokinetics during voriconazole co-therapy: a drug-drug interaction study in liver transplant recipients. [PDF]

Ther Adv Drug Saf
Li J, Li L, Xia Y, Chen J, Li J, Lin X, Chen X, Tang KJ, Chen P, Liu X.   +9 more
europepmc   +1 more source

Case Report: Pediatric isavuconazole supratherapeutic exposure: a case of long-term use, CYP3A5 poor metabolizer genotype and concomitant CYP3A4 medications. [PDF]

Front Pharmacol
Liu M, Li L, Zhou C, Luo C, Wang X, Wu J.   +5 more
europepmc   +1 more source